Literature DB >> 31482695

Neuroprotective Effect of Nerve Growth Factor Loaded in Porous Silicon Nanostructures in an Alzheimer's Disease Model and Potential Delivery to the Brain.

Neta Zilony-Hanin1,2, Michal Rosenberg3, Michal Richman4, Ronen Yehuda5, Hadas Schori1, Menachem Motiei1,2, Shai Rahimipour4, Alexander Groisman6, Ester Segal3,7, Orit Shefi1,2.   

Abstract

Nerve growth factor (NGF) plays a vital role in reducing the loss of cholinergic neurons in Alzheimer's disease (AD). However, its delivery to the brain remains a challenge. Herein, NGF is loaded into degradable oxidized porous silicon (PSiO2 ) carriers, which are designed to carry and continuously release the protein over a 1 month period. The released NGF exhibits a substantial neuroprotective effect in differentiated rat pheochromocytoma PC12 cells against amyloid-beta (Aβ)-induced cytotoxicity, which is associated with Alzheimer's disease. Next, two potential localized administration routes of the porous carriers into murine brain are investigated: implantation of PSiO2 chips above the dura mater, and biolistic bombardment of PSiO2 microparticles through an opening in the skull using a pneumatic gene gun. The PSiO2 -implanted mice are monitored for a period of 8 weeks and no inflammation or adverse effects are observed. Subsequently, a successful biolistic delivery of these highly porous microparticles into a live-mouse brain is demonstrated for the first time. The bombarded microparticles are observed to penetrate the brain and reach a depth of 150 µm. These results pave the way for using degradable PSiO2 carriers as potential localized delivery systems for NGF to the brain.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Alzheimer's disease; biolistics; brain; delivery; nerve growth factor; porous silicon

Mesh:

Substances:

Year:  2019        PMID: 31482695     DOI: 10.1002/smll.201904203

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  7 in total

1.  Porous Silicon Nanoparticles Targeted to the Extracellular Matrix for Therapeutic Protein Delivery in Traumatic Brain Injury.

Authors:  Lauren E Waggoner; Jinyoung Kang; Jonathan M Zuidema; Sanahan Vijayakumar; Alan A Hurtado; Michael J Sailor; Ester J Kwon
Journal:  Bioconjug Chem       Date:  2022-08-26       Impact factor: 6.069

Review 2.  Advances in Laser Ablation Synthesized Silicon-Based Nanomaterials for the Prevention of Bacterial Infection.

Authors:  Marina Martínez-Carmona; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2020-07-24       Impact factor: 5.076

3.  β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease.

Authors:  Nanbu Wang; Haoyu Wang; Lingyu Li; Yunchuan Li; Ronghua Zhang
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

4.  Bone Morphogenic Protein 2-Loaded Porous Silicon Carriers for Osteoinductive Implants.

Authors:  Michal Rosenberg; Dekel Shilo; Leonid Galperin; Tal Capucha; Karim Tarabieh; Adi Rachmiel; Ester Segal
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

Review 5.  Role of micronutrients in Alzheimer's disease: Review of available evidence.

Authors:  Hong-Xin Fei; Chao-Fan Qian; Xiang-Mei Wu; Yu-Hua Wei; Jin-Yu Huang; Li-Hua Wei
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

6.  Expression Profiling and Cell Type Classification Analysis in Periodontitis Reveal Dysregulation of Multiple lncRNAs in Plasma Cells.

Authors:  Donglei Wu; Peng Zhou; Fengdi Cao; Zhengshen Lin; Defeng Liang; Xincai Zhou
Journal:  Front Genet       Date:  2020-04-28       Impact factor: 4.599

Review 7.  Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement.

Authors:  Gabriela Dumitrita Stanciu; Andrei Luca; Razvan Nicolae Rusu; Veronica Bild; Sorin Ioan Beschea Chiriac; Carmen Solcan; Walther Bild; Daniela Carmen Ababei
Journal:  Biomolecules       Date:  2019-12-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.